Sara Pilotto

Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin‐remodelling genes as major players and a prognostic role for <i><scp>TERT</scp></i>, <i><scp>RB1</scp></i>, <i><scp>MEN1</scp></i> and <scp><i>KMT2D</i></scp>

Michele Simbolo, Andrea Mafficini, Katarzyna Sikora et al. · The Journal of Pathology · 2016 · 224 citations · Full text

Targeted Ngs, World Health Organization, Engineering +24

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

Imane Chaib, Niki Karachaliou, Sara Pilotto et al. · JNCI Journal of the National Cancer Institute · 2017 · 216 citations · Full text

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri et al. · European Journal of Cancer · 2020 · 145 citations · Full text

First-line Pembrolizumab, Medicine, Pathology +6

Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations

Michele Simbolo, Stefano Barbi, Matteo Fassan et al. · Journal of Thoracic Oncology · 2019 · 103 citations · Full text

ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)

Rita Chiari, Biagio Ricciuti, Lorenza Landi et al. · Clinical Lung Cancer · 2019 · 97 citations

Thrombosis, Venous Thrombosis, Phase Ii +11